Rentschler Biopharma SE

Rentschler Biopharma Announces New State-of-the-Art Production Line in Massachusetts is Fully Operational

Rentschler Biopharma Appoints Patrick Meyer as Global Head BD Sales and Alliance Management

Rentschler Biopharma Appoints Patrick Cushing as VP Operations for U.S. Subsidiary

Rentschler Biopharma contributes to nearly 25% of FDA approved biopharmaceuticals in 2023

Senta Brandt and Gerrick Rodrigues appointed to Global Leadership Positions at Rentschler Biopharma

Rentschler Biopharma Announces Major Client Project for New U.S. Facility at Milford, MA Site

Rentschler Biopharma SE appoints Gunnar Voss von Dahlen as Chief Financial Officer and completes Executive Board

Dr. Günter Stempfer appointed Site Head Laupheim for Rentschler Biopharma

Dr. Björn Beckmann Appointed Head of Quality Control at Rentschler Biopharma’s Laupheim Site

Rentschler Biopharma und Friedrich-Adler-Realschule Laupheim schließen Kooperationsvertrag zur Förderung von Schulbildung mit zusätzlichem Praxisbezug

Rentschler Biopharma appoints Benedikt von Braunmuehl as Chief Executive Officer and Tom Roberts as President and General Manager U.S.

Rentschler Biopharma’s ATMP facility in UK receives MHRA approval

Rentschler Biopharma SE : Dr. Dominik Kugelstadt joins as Head of Clinical and Commercial Manufacturing, Laupheim

Rentschler Biopharma joins forces with Ikarovec to accelerate novel gene therapies for treatment of ophthalmic disease

Rentschler Biopharma unterstützt als „Planetenpartner“ das Planetarium Laupheim mit 25.000 Euro

Rentschler Biopharma appoints Thomas aus dem Siepen as Global Head Digital Manufacturing and Automation

Rentschler Biopharma’s service excellence recognized with CDMO Leadership Awards and Champion status

Rentschler Biopharma awarded Chiesi Supplier Award

Rentschler implements innovative learning program in collaboration with MassBioEd and WPI

After seven years of accelerated growth at Rentschler Biopharma SE under his leadership as CEO, Dr. Frank Mathias to return to the Supervisory Board

Rentschler Biopharma appoints Christiane Bardroff as Chief Operating Officer and Member of the Executive Board

Rentschler Biopharma appoints Tobias Glueck as SVP Human Relations

Rentschler Biopharma appoints Mark Caswell as Vice President, Site Head for US Facility

Rentschler Biopharma Expands Leadership Team with Senior-Level Hires

Rentschler Biopharma adds highly experienced executive to team and provides update on progress at Rentschler ATMP

Rentschler Biopharma further strengthens Company Leadership Team

Rentschler Biopharma reports strong growth and continues hiring at all three sites

Rentschler Biopharma appoints Dr. Robert Panting as General Manager of Rentschler ATMP Ltd., Center of Excellence for Cell and Gene Therapy

Rentschler Biopharma and XL-protein: Efficient production of a hyperactive PASylated DNase I with extended half-life

Rentschler Biopharma Inc. Recognized by Massachusetts House of Representatives as Manufacturer of the Year for District